|83 General Warren Blvd, Ste. 170 , Malvern, PA 19355|
|Fund Manager||Bruce R. Berkowitz|
|Manager Tenure||21 Years 9 Months|
The Fairholme Funds investment objective is long-term growth of capital. Fairholme Capital Management, L.L.C. (the Manager), the investment adviser to The Fairholme Fund, attempts, under normal circumstances, to achieve The Fairholme Funds investment objective by investing in a focused portfolio of equity and fixed-income securities. The proportion of The Fairholme Funds assets invested in each type of asset class will vary from time to time based upon the Managers assessment of general market and economic conditions. The Fairholme Fund may invest in, and may shift frequently among, asset classes and market sectors.The equity securities in which The Fairholme Fund may invest include common and preferred stock (including convertible preferred stock), partnership interests,business trust shares, depository receipts, rights and warrants to subscribe for the purchase of equity securities, and interests in real estate investment trusts(REITs).
|Asset Type||% Of Allocation|
|Total Net Assets||1.44 B|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$6000|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 06/30/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 06/30/2021|
|Life Of Fund||
Join the Action Alerts PLUS Community today!
Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.
Jim Cramer discusses Ford and the impact of the impending tax policy changes on the stock market.